| Diabetes Drug Shows Potential For Treating One Cause Of Chronic ... - Science Daily (press release) |
|
|
Phase I Trial of Rosiglitazone in FSGS: I. Report of the FONT Study Group. Clinical Journal of the American Society Nephrology, Online December 10, 2008; ... |